#Japan #Nagoya #Preventive Medicine #MIT Jameel Clinic #Jameel Corporation

Seminar Overview

On May 29, 2026, Jameel Corporation hosted a crucial seminar during the 28th Japanese Society for Medical Management Congress in Nagoya. With the collaboration of the MIT Jameel Clinic, renowned for its focus on AI in medicine, the seminar was titled "Exploring the Future of Preventive Medicine with AI - Moving from 'Detecting' to 'Preventing' Healthcare."

The event attracted around 200 medical professionals, showcasing a strong interest in preventive healthcare and the application of AI in this domain. Leading the discussions was Professor Toshiki Mano from Chuo University, alongside prominent speakers including Dr. Mitsuhiro Hayashi, head of the breast surgery department at Yotsuya Medical Cube, Dr. Nacer Mami from MIT Jameel Clinic, and Dr. Ayumi Saito from the National Cancer Center Hospital.

Key Themes

The seminar focused on the transition from traditional detection methods to proactive preventive measures. Attendees learned about AI-driven cancer risk prediction models developed by MIT Jameel Clinic, namely "MIRAI" and "SYBIL."

• - MIRAI offers predictions of breast cancer risk up to five years ahead based on mammography images.
• - SYBIL, on the other hand, provides lung cancer risk forecasts up to six years in advance from a single low-dose CT scan.

In addition to these models, the seminar highlighted international examples of preventive healthcare applications and ongoing collaborative research initiatives within Japan.

Importance of Local Evidence

One of the focal points was the necessity of building evidence based on Japanese patient data. Discussions centered on the domestic collaborative research involving both the National Cancer Center Hospital and Yotsuya Medical Cube. These efforts aim to explore the feasibility and potential challenges of implementing MIRAI and SYBIL in Japan's healthcare system.

Implications for the Future

This seminar represented a significant milestone towards realizing predictive and personalized preventive healthcare in Japan. By sharing insights on innovative AI applications, the event reinforced the commitment to advancing the "preventive healthcare" paradigm. Participants engaged in vigorous discussions, facilitating a clearer understanding of the future landscape of healthcare leveraging AI.

The collaboration between Jameel Corporation and MIT Jameel Clinic underscores their shared vision of enhancing community health through technology and education. As these AI models continue to evolve, their impact on reducing cancer risks and improving patient outcomes will likely become more pronounced.

In conclusion, this seminar not only highlighted the incredible potential of AI in preventive medicine but also served as a clarion call for continued research and collaboration to build a healthier future for all.